Modified Nucleotide Capped RNA via Enzymatic Capping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing capped RNA transcripts are inefficient, leading to low yields and purity issues, particularly when using dinucleotide cap analogs, which result in reverse orientation incorporation and reduced translational efficiency, and there is a need for easier, faster, and more cost-effective ways to produce modified nucleotide-capped RNA with improved properties.
Innovation Solution
Utilizing a capping enzyme system, such as vaccinia virus capping enzyme, with modified cap nucleotides to catalyze the formation of modified-nucleotide-capped RNA, achieving high capping efficiency and yield, and incorporating a 2′-O-methyltransferase to obtain capped RNA with a cap I structure, which enhances translational efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If dinucleotide cap analogs are used for synthesizing capped RNA transcripts, then capping can be achieved, but reverse orientation incorporation occurs and translational efficiency is reduced
Solution Approach 1:
The patent uses a capping enzyme system (RNA triphosphatase, RNA guanyltransferase, and guanine-7-methyltransferase) as an intermediary to mediate the capping process. The enzyme system ensures correct orientation incorporation of the cap structure by catalyzing the reaction in a controlled manner, preventing the reverse orientation problems associated with direct dinucleotide cap analog incorporation.
Solution Approach 2:
The patent changes the reaction parameters by using enzymatic catalysis instead of direct chemical incorporation. The enzyme system alters the reaction conditions to favor correct orientation cap incorporation, achieving both high capping efficiency and proper orientation through biochemical parameter optimization.
2Productivity
If traditional capping methods are used, then capped RNA can be produced, but yields are low and purity issues occur
Solution Approach 1:
The capping enzyme system acts as an intermediary that enables high-yield production of capped RNA with improved purity. The enzymatic approach allows for selective capping of target RNA molecules while minimizing side reactions and contamination, thereby simultaneously improving both yield and purity.
Solution Approach 2:
The patent replaces traditional chemical capping methods with an enzymatic system. This substitution of chemical mechanics with biochemical catalysis enables more precise control over the capping reaction, resulting in higher yields and better purity by reducing non-specific reactions and byproduct formation.
3Adaptability or versatility
If modified cap nucleotides are synthesized using traditional methods, then modified-nucleotide-capped RNA can be obtained, but the process is difficult, time-consuming, and expensive
Solution Approach 1:
The capping enzyme system serves as an intermediary that simplifies the incorporation of modified cap nucleotides. Instead of requiring complex chemical synthesis procedures, the enzyme system catalyzes the incorporation of modified nucleotides directly, making the process easier, faster, and more cost-effective while maintaining versatility.
Solution Approach 2:
The patent replaces complex chemical synthesis mechanisms with enzymatic catalysis for incorporating modified cap nucleotides. This substitution dramatically reduces the time and cost required for synthesis while maintaining the ability to incorporate various modified nucleotide types, thereby improving ease of manufacture without sacrificing adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves nearly 100% capping efficiency, higher yields, and improved translational efficiency compared to traditional methods, producing capped RNA with enhanced stability and functionality for various applications, including medical and research uses.
Implementation Method 1
contacting the uncapped RNA with the capping enzyme system and the modified cap nucleotide under conditions wherein modified-nucleotide-capped RNA is synthesized
Implementation Method 2
incorporating a 2′-O-methyltransferase to obtain capped RNA with a cap I structure
Data Source
AI summary
The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.